Changes in peanut-specific T-cell clonotype with oral immunotherapy.
Department of Pediatrics, Sainte-Justine Hospital, Montreal, Quebec, Canada; Department of Medicine, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: philippe.begin@umontreal.ca.
Philippe
P
Bégin
Division of Allergy, Immunology and Rheumatology, Sean N. Parker Center for Allergy Research at Stanford University, Stanford University School of Medicine, Stanford, Calif.
Kari C
KC
Nadeau
D000293:Adolescent; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology*; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D010367:Arachis / Q000737:chemistry / Q000276:immunology; D065150:Cellular Reprogramming; D002648:Child; D002675:Child, Preschool; D002999:Clone Cells; D005260:Female; D015870:Gene Expression; D006801:Humans; D008297:Male; D000069444:Omalizumab; D021183:Peanut Hypersensitivity / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010940:Plant Proteins / Q000008:administration & dosage / Q000276:immunology*; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology; D063729:Sublingual Immunotherapy; D018417:Th1 Cells / Q000276:immunology* / Q000473:pathology; D018418:Th2 Cells / Q000276:immunology* / Q000473:pathology
D000485:Allergens; D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D010940:Plant Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D000069444:Omalizumab